HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Increase of nucleotidase activities in rat blood serum after a single convulsive injection of pentylenetetrazol.

Abstract
Adenosine has been shown to be a major regulator in convulsive disorders exerting its anticonvulsant effects on various seizure models. The ectonucleotidase pathway is an important metabolic source of extracellular adenosine. In this study, we evaluated ATP, ADP and AMP hydrolysis in rat serum after a single convulsive injection of pentylenetetrazol (PTZ). The animals were sacrificed at 5 and 30 min, 1, 5, 12, 24 and 48 h after an intraperitoneal injection of PTZ (60 mg/kg). ATP, ADP and AMP hydrolysis by rat blood serum were significantly increased (40-50%) until 24 h after PTZ injection. There were no significant differences in the nucleotide hydrolysis when the in vitro effect of different concentrations of PTZ was analyzed. Changes in nucleotide hydrolysis observed after acute administration of PTZ could not be attributed to phosphodiesterase activity since PTZ-treated rats did not demonstrate significant differences in the hydrolysis of the substrate marker of this enzyme when compared with control rats. These results suggest that the stimulation of the nucleotidase pathway may play an important role in attenuating seizure activity.
AuthorsAlessandra Nejar Bruno, Jean Pierre Oses, Carla Denise Bonan, Roger Walz, Ana Maria Oliveira Battastini, João José Freitas Sarkis
JournalNeuroscience research (Neurosci Res) Vol. 43 Issue 3 Pg. 283-8 (Jul 2002) ISSN: 0168-0102 [Print] Ireland
PMID12103446 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Nucleotidases
  • nucleotidase
  • Pentylenetetrazole
Topics
  • Animals
  • Dose-Response Relationship, Drug
  • Female
  • Injections, Intraperitoneal
  • Nucleotidases (blood)
  • Pentylenetetrazole (administration & dosage, adverse effects)
  • Rats
  • Rats, Wistar
  • Seizures (blood, chemically induced, enzymology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: